2016 Updated EULAR Recommendations for Management of flares in patients with Gout

Management of acute flare according to the European League Against Rheumatism recommendations. Letters and numbers in parentheses indicate the items of the recommendations presented in the table. Strong P-glycoprotein or CYP3A4 inhibitors are cyclosporin, clarithromycin, ketoconazole and ritonavir. IL, interleukin; NSAID, non-steroidal anti-inflammatory drug; PPI, proton pump inhibitor; ULT, urate-lowering therapy.

Table adapted from: Richette P, Doherty M, Pascual E, et al.  “2016 updated EULAR evidence-based recommendations for the management of gout.” Annals of the Rheumatic Diseases 2017;76:29-42.


Discover more from Rheumatology TT

Subscribe to get the latest posts sent to your email.